Analysts think ELUT stock price could increase by 31%
Jun 14, 2024, 6:30 AM
-5.91%
What does ELUT do
Aziyo Biologics, Inc., a commercial-stage biotechnology company based in Silver Spring, Maryland, specializes in drug-eluting biologic technologies including the CanGaroo Envelope for cardiac device stabilization and SimpliDerm Acellular Dermal Matrix for breast reconstruction. The company, which went public in 2020, employs 107 people and is developing CanGaroo RM, which incorporates antibiotics for sustained delivery at surgical sites.
4 analysts think ELUT stock price will increase by 31.11%. The current median analyst target is $5.10 compared to a current stock price of $3.89. The lowest analysts target is $5.05 and the highest analyst target is $5.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
